相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents
Nikolaos G. Almyroudis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp.
PA Warn et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers
A Schmitt-Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Changing patterns and trends in systemic fungal infections
MD Richardson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Infections due to emerging and uncommon medically important fungal pathogens
TJ Walsh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-Rich antigen
R Bialek et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates
B Minassian et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study
A Espinel-Ingroff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum
RK Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
